3 results match your criteria: "Norway. deidi.bergestuen@rikshospitalet.no[Affiliation]"
Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis.
Neuroendocrinology
February 2011
Section of Gastroenterology, Department of Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Background/aims: Carcinoid heart disease (CHD), a complication of neuroendocrine tumors (NETs), is characterized by right heart fibrotic lesions. Though serotonin is likely involved, the pathogenesis of CHD remains unclear. Cytokines and growth factors with fibrogenic properties may play a role.
View Article and Find Full Text PDFPlasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors.
BMC Cancer
January 2010
Section of Gastroenterology, Department of Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0027 Oslo, Norway.
Background: Carcinoid heart disease, a known complication of neuroendocrine tumors, is characterized by right heart fibrotic lesions. Carcinoid heart disease has traditionally been defined by the degree of valvular involvement. Right ventricular (RV) dysfunction due to mural involvement may also be a manifestation.
View Article and Find Full Text PDFSmall intestinal neuroendocrine tumors: prognostic factors and survival.
Scand J Gastroenterol
February 2010
Department of Medicine, Section of Gastroenterology, Rikshospitalet University Hospital, Oslo, Norway.
Objective: Small intestinal neuroendocrine tumors (SI-NETs) make up 38% of gastroenteropancreatic neuroendocrine tumors. We report our experience with SI-NETs at the National Center for Neuroendocrine Tumors in Norway, focusing on prognostic factors and survival.
Material And Methods: The medical records of 258 patients with SI-NETs diagnosed between 1983 and 2007 were retrospectively reviewed.